
CAS 1030612-90-8: MK-8245
Description:MK-8245, with the CAS number 1030612-90-8, is a chemical compound that has been investigated primarily for its potential therapeutic applications, particularly in the field of oncology. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in targeting specific types of cancer cells. The compound exhibits a unique molecular structure that allows it to interact with specific proteins involved in cell signaling and proliferation. MK-8245 has undergone various stages of clinical trials to evaluate its safety, tolerability, and effectiveness in treating particular malignancies. As with many investigational drugs, its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for understanding its potential therapeutic window and side effect profile. Ongoing research continues to elucidate its mechanism of action and optimize its use in clinical settings.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | MK-8245 REF: 54-BUP00259CAS: 1030612-90-8 | 99% | 414.00 € | Mon 21 Apr 25 |
![]() | MK-8245 REF: TM-T2650CAS: 1030612-90-8 | 97.58% - 99% | 39.00 €~467.00 € | Tue 29 Apr 25 |

MK-8245
Ref: TM-T2650
1mg | 39.00 € | ||
2mg | 51.00 € | ||
5mg | 96.00 € | ||
10mg | 153.00 € | ||
25mg | 273.00 € | ||
50mg | 467.00 € | ||
1mL*10mM (DMSO) | 97.00 € |